Send to

Choose Destination
Biochemistry. 1994 Nov 8;33(44):13070-8.

Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms.

Author information

Department of Pharmaceutical Chemistry, University of California, San Francisco 94143-0446.


Haemophilus ducreyi is a sexually transmitted pathogen that colonizes the genital epithelium in humans, causing genital ulcers or chancroid. Its surface lipooligosaccharides (LOSs) have been shown to play a role in ulcer formation and may also be important in cell adhesion and invasion of host tissue. Earlier we presented a preliminary structure of the major LOS from strain 35000 that suggested the presence of terminal lactosamine [Melaugh, W., Phillips, N.J., Campagnari, A.A., Karalus, R., & Gibson, B. W. (1992) J. Biol. Chem. 267, 13434-13439]. We have now confirmed this structure and assigned the anomeric linkages by 2D NMR studies. In addition to this major structure, analysis by electrospray ionization mass spectrometry of both O-deacylated LOSs and the oligosaccharides released after treatment with mild acid indicates the presence of several other LOS glycoforms. These glycoforms constitute a series of both truncated and elongated analogs of the major oligosaccharide determined by NMR. One of these glycoforms exists as a smaller oligosaccharide corresponding to the major structure minus terminal galactose. Three other glycoforms appear as larger molecular weight species formed by the addition of phosphoethanolamine, N-acetylhexosamine, and N-acetylhexosamine plus hexose. Two sialylated glycoforms were also identified and subsequently confirmed by treatment with neuraminidase, but these glycoforms were not found in the released oligosaccharide pool due to the acid lability of of sialic acid. This study clearly indicates that the LOSs from H. ducreyi strain 35000 exist as a heterogeneous population whose structures differ primarily in their phosphorylation states and terminal sugars and whose terminal glycan structures can resemble those of human antigens.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center